Jump to content

PYC - PYC THERAPEUTICS LIMITED


ShareCafe

Recommended Posts

  • Replies 1.5k
  • Created
  • Last Reply

Top Posters In This Topic

Top Posters In This Topic

Posted Images

Once upon a time, Merck paid US$1.1bn CASH for a company called Sirna. At the time their lead candidate was for macular degeneration. Very similar to retinitis pigmentosa. They made a total hash of it. Lost key people and the IP wasn't that great in the end. It ended up in the ALNY stable for pennies on the dollar.

 

https://www.nature.com/articles/d41586-019-03069-3

 

Not stated in the article is as time would show, the Sirna deal became the high tide mark for RNAi companies.

 

Which means, if PYC is to be sold or have a cornerstone partner, most likely Merck, then the valuation must be able to match the Sirna deal.

 

Currently, the valuation is about half a billion. Therefore, there must be at least double the value to be had. That makes it approximately, 30c. Anything less and I reckon Junior and Senior have failed. But then we don't know the true details of the AMGN-FPRX deal.

Link to comment
Share on other sites

Same again today. Someone does not want 17c breached.

 

Once again they are taking the quarterly right to the very end. You'd think if they were actually on their game it wouldn't matter when they released it.

 

Link to comment
Share on other sites

A big day for PYC today. The quarterly is to be released. Whoop, whoop.

 

More doughnuts coming. May tomorrow. Christmas soon.

 

Alnylam finger prints all over this thing previously, now they're Merck's and still nothing. AMGN - FPRX do their deal then a change of control. Just a coincidence I am sure. No leaky back door here.

 

Link to comment
Share on other sites

Speaking of Amgen, I can recall all the HC pumptards getting themselves excited when a dude called Bioexec joined in the conversation. Obviously a knowledgeable guy. So much so, that some of the pumptards were making inferences about him being an Amgen employee. Now, all this time later, they do a deal with FPRX.

 

I mean, it must be just bad luck that PYC never seems to end up having anything anyone wants to buy.

 

Link to comment
Share on other sites

Merck proxies crowding into PYC tells us the results of the upcoming read out are probably already known. These people wouldn't be involving themselves with a loser. What needs answering is, does good news fit with the plan or do they prefer to paint it as bad to knock the price down?
Link to comment
Share on other sites

Things must be heating up in this space. Once upon a time there was a JCC on the board of PYC. He is now involved in a takeover for his current company.

It is an indication the winter thaw is underway.

Perhaps we can expect a takeover at PYC. Or is this new American gang going to try and do a BLT on PYC so they can buy it for pennies? Especially now since the AMGN deal got done with PYC clone, FPRX.

 

Link to comment
Share on other sites

Closing price sitting on the 100 day MA in the middle of May just as JCC's new company is subject to a takeover and another one is underway at BLD.

 

Perhaps we will see one here but I have been told there will be one at CSL.

 

30c takes it to about a billion. Or about 30c will take it to a billion. MRK buying Sirna for US$1.1bn was the high tide mark.

 

Anyone will take a 100% premium and the real estate guy will be thinking, why did I ever bother with real estate?

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

×
×
  • Create New...